Edition:
India

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

4.26USD
16 Jan 2018
Change (% chg)

$0.01 (+0.24%)
Prev Close
$4.25
Open
$4.35
Day's High
$4.36
Day's Low
$4.11
Volume
34,740
Avg. Vol
35,930
52-wk High
$4.44
52-wk Low
$1.84

Select another date:

Tue, Dec 5 2017

BRIEF-Sunesis Pharmaceuticals Inc - Daniel Swisher Resigns As CEO Effective End Of 2017

* SUNESIS PHARMACEUTICALS INC - DANIEL SWISHER RESIGNS AS CEO EFFECTIVE END OF 2017

BRIEF-Sunesis Pharmaceuticals Appoints William Quinn As CFO

* SUNESIS PHARMACEUTICALS APPOINTS WILLIAM QUINN AS CHIEF FINANCIAL OFFICER AND SENIOR VICE PRESIDENT, FINANCE AND CORPORATE DEVELOPMENT

BRIEF-RA Capital Management reports 10.4 pct passive stake in Sunesis Pharmaceuticals as of Oct 25

* RA Capital Management reports 10.4 percent passive stake in Sunesis Pharmaceuticals as of October 25 – SEC Filing‍​ Source text: [http://bit.ly/2yZzSQ5] Further company coverage:

BRIEF-Sunesis Pharmaceuticals Inc Q3 loss per share ‍$0.43​

* Sunesis Pharmaceuticals reports third quarter 2017 financial results and recent highlights

BRIEF-Sunesis announces pricing of $20 million offering of securities

* Sunesis announces pricing of $20 million offering of securities

BRIEF-Sunesis Pharmaceuticals announces proposed public offering of common stock, preferred stock and warrants

* Sunesis announces proposed public offering of common stock, preferred stock and warrants

BRIEF-Sunesis Pharmaceuticals reports second quarter results

* Sunesis Pharmaceuticals reports second quarter 2017 financial results and recent highlights

Select another date: